Delivery Order SPE2DB24D2205-SPE2DB25FDZSP

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.53 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a topical medication. The award has an ultimate completion date of September 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,681.13, is a delivery order for 4568038421 - Pimecrolimus 1% Cream 100GM. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,579.48 Firm Fixed Price Delivery Order contract is for the supply of PIMECROLIMUS 1% CREAM 100GM, a topical medication. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.79 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 30gm, a pharmaceutical product, with a performance period ending on April 18, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,701.62 delivery order is for the supply of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, to support military healthcare programs. The contract is a firm-fixed-price agreement with a period of performance through March 1, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,200.38, is for the delivery of PIMECROLIMUS 1% CREAM 100GM. The contract has an ultimate completion date of September 29, 2023 and is a firm-fixed price delivery order. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,599.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a medical product, with a completion date of March 5, 2025. The contract is a Delivery Order and has a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,788.52 firm fixed-price contract is for the supply of PIMECROLIMUS 1% CREAM 30GM, a topical medication. This contract is not designated as a set-aside. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
This federal contract award, identified as SPE2DB22D2206|SPE2DB24FHH74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,598.50, is for the delivery of Pimecrolimus 1% Cream in 30-gram quantities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN3B5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pimecrolimus 1% Cream, a topical medication, with a ceiling value of $1,022.54 and a period of performance through April 7, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDZSP
    Delivery Order

This federal contract award, with ID SPE2DB24D2205|SPE2DB25FDZSP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,551.48 firm fixed-price delivery order is for the supply of 4567602351 - Pimecrolimus 1% Cream 30GM, with a completion date of March 18, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/16/25, 10:51 AM